FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3131448108> ?p ?o ?g. }

• W3131448108 endingPage "801" @default.
• W3131448108 startingPage "801" @default.
• W3131448108 abstract "The Novel Coronavirus Disease 2019 (COVID-19) has swept the world and caused a global pandemic. SARS-CoV-2 seems to have originated from bats as their reservoir hosts over time. Similar to SARS-CoV, this new virus also exerts its action on the human angiotensin-converting enzyme 2. This action causes infections in cells and establishes an infectious disease, COVID-19. Against this viral invasion, the human body starts to activate the innate immune system in producing and releasing proinflammatory cytokines such as IL-6, IL-1β, IL-8, TNF-α, and other chemokines, such as G-CSF, IP10 and MCPl, which all develop and increase the inflammatory response. In cases of COVID-19, excessive inflammatory responses occur, and exaggerated proinflammatory cytokines and chemokines are detected in the serum, resulting in cytokine release syndrome or cytokine storm. This causes coagulation abnormalities, excessive oxidation developments, mitochondrial permeability transition, vital organ damage, immune system failure and eventually progresses to disseminated intravascular coagulation and multiple organ failure. Additionally, the excessive inflammatory responses also cause mitochondrial dysfunction due to progressive and persistent stress. This damages cells and mitochondria, leaving products containing mitochondrial DNA and cell debris involved in the excessive chronic inflammation as damage-associated molecular patterns. Thus, the respiratory infection progressively leads to disseminated intravascular coagulation from acute respiratory distress syndrome, including vascular endothelial cell damage and coagulation-fibrinolysis system disorders. This condition causes central nervous system disorders, renal failure, liver failure and, finally, multiple organ failure. Regarding treatment for COVID-19, the following are progressive and multiple steps for mitigating the excessive inflammatory response and subsequent cytokine storm in patients. First, administering of favipiravir to suppress SARS-CoV-2 and nafamostat to inhibit ACE2 function should be considered. Second, anti-rheumatic drugs (monoclonal antibodies), which act on the leading cytokines (IL-1β, IL-6) and/or cytokine receptors such as tocilizumab, should be administered as well. Finally, melatonin may also have supportive effects for cytokine release syndrome, resulting in mitochondrial function improvement. This paper will further explore these subjects with reports mostly from China and Europe." @default.
• W3131448108 created "2021-03-01" @default.
• W3131448108 creator A5022049181 @default.
• W3131448108 creator A5075784335 @default.
• W3131448108 creator A5081069755 @default.
• W3131448108 creator A5090769439 @default.
• W3131448108 date "2021-02-17" @default.
• W3131448108 modified "2023-10-12" @default.
• W3131448108 title "Novel Coronavirus Disease 2019 (COVID-19) and Cytokine Storms for More Effective Treatments from an Inflammatory Pathophysiology" @default.
• W3131448108 cites W1966238900 @default.
• W3131448108 cites W2005607780 @default.
• W3131448108 cites W2013895299 @default.
• W3131448108 cites W2043240738 @default.
• W3131448108 cites W2060004514 @default.
• W3131448108 cites W2114244238 @default.
• W3131448108 cites W2120852203 @default.
• W3131448108 cites W2134390470 @default.
• W3131448108 cites W2138677670 @default.
• W3131448108 cites W2146494489 @default.
• W3131448108 cites W2177407033 @default.
• W3131448108 cites W2509449660 @default.
• W3131448108 cites W2544056465 @default.
• W3131448108 cites W2606232917 @default.
• W3131448108 cites W2610420640 @default.
• W3131448108 cites W2745922079 @default.
• W3131448108 cites W2770269726 @default.
• W3131448108 cites W2790527681 @default.
• W3131448108 cites W2800684479 @default.
• W3131448108 cites W28510732 @default.
• W3131448108 cites W2887324910 @default.
• W3131448108 cites W2914084525 @default.
• W3131448108 cites W2954782052 @default.
• W3131448108 cites W3001118548 @default.
• W3131448108 cites W3002108456 @default.
• W3131448108 cites W3004894342 @default.
• W3131448108 cites W3007238890 @default.
• W3131448108 cites W3007940623 @default.
• W3131448108 cites W3008028633 @default.
• W3131448108 cites W3009198809 @default.
• W3131448108 cites W3009739970 @default.
• W3131448108 cites W3009951436 @default.
• W3131448108 cites W3011176674 @default.
• W3131448108 cites W3012612692 @default.
• W3131448108 cites W3012655019 @default.
• W3131448108 cites W3012706084 @default.
• W3131448108 cites W3012721127 @default.
• W3131448108 cites W3012921204 @default.
• W3131448108 cites W3013270768 @default.
• W3131448108 cites W3013365475 @default.
• W3131448108 cites W3013442544 @default.
• W3131448108 cites W3013601745 @default.
• W3131448108 cites W3013768434 @default.
• W3131448108 cites W3013929252 @default.
• W3131448108 cites W3014050022 @default.
• W3131448108 cites W3021024241 @default.
• W3131448108 cites W3022970339 @default.
• W3131448108 cites W3031365196 @default.
• W3131448108 cites W3042257644 @default.
• W3131448108 cites W3044321702 @default.
• W3131448108 cites W3092887721 @default.
• W3131448108 cites W3093604087 @default.
• W3131448108 cites W3110844195 @default.
• W3131448108 cites W3111784373 @default.
• W3131448108 cites W3113314553 @default.
• W3131448108 cites W3118579436 @default.
• W3131448108 cites W3119820680 @default.
• W3131448108 doi "https://doi.org/10.3390/jcm10040801" @default.
• W3131448108 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7922214" @default.
• W3131448108 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33671159" @default.
• W3131448108 hasPublicationYear "2021" @default.
• W3131448108 type Work @default.
• W3131448108 sameAs 3131448108 @default.
• W3131448108 citedByCount "30" @default.
• W3131448108 countsByYear W31314481082021 @default.
• W3131448108 countsByYear W31314481082022 @default.
• W3131448108 countsByYear W31314481082023 @default.
• W3131448108 crossrefType "journal-article" @default.
• W3131448108 hasAuthorship W3131448108A5022049181 @default.
• W3131448108 hasAuthorship W3131448108A5075784335 @default.
• W3131448108 hasAuthorship W3131448108A5081069755 @default.
• W3131448108 hasAuthorship W3131448108A5090769439 @default.
• W3131448108 hasBestOaLocation W31314481081 @default.
• W3131448108 hasConcept C13373296 @default.
• W3131448108 hasConcept C142724271 @default.
• W3131448108 hasConcept C164027704 @default.
• W3131448108 hasConcept C203014093 @default.
• W3131448108 hasConcept C2776914184 @default.
• W3131448108 hasConcept C2778690821 @default.
• W3131448108 hasConcept C2779134260 @default.
• W3131448108 hasConcept C2779559532 @default.
• W3131448108 hasConcept C3008058167 @default.
• W3131448108 hasConcept C524204448 @default.
• W3131448108 hasConcept C71924100 @default.
• W3131448108 hasConcept C8891405 @default.
• W3131448108 hasConceptScore W3131448108C13373296 @default.
• W3131448108 hasConceptScore W3131448108C142724271 @default.
• W3131448108 hasConceptScore W3131448108C164027704 @default.
• W3131448108 hasConceptScore W3131448108C203014093 @default.

• next